Is it necessary to get the HPV bivalent vaccine?
Generally speaking, HPV refers to human papillomavirus, and the bivalent human papillomavirus vaccine refers to the double-type human papillomavirus vaccine. Whether vaccination is necessary mainly depends on individual age and previous vaccination history. If one is under the age of 25 and has not previously received other human papillomavirus vaccines, vaccination is usually recommended. However, if one is over the age of 25 or has a prior vaccination history, it is generally not recommended. Detailed analysis is as follows:
If someone has never received the human papillomavirus vaccine before and is currently between the ages of 9 and 25, it is generally advisable to receive the bivalent human papillomavirus vaccine. This vaccine can protect against human papillomavirus types 16 and 18, thus preventing cervical cancer, vaginal cancer, and other diseases caused by these two virus types.
However, if there is a prior vaccination history, such as having received the quadrivalent or nine-valent human papillomavirus vaccines, and the individual is over the age of 25, he or she does not meet the vaccination criteria. Therefore, receiving the bivalent human papillomavirus vaccine is unnecessary.
Before receiving the bivalent human papillomavirus vaccine, it is recommended to understand medication-related information and one's personal health status. Individuals who are allergic to vaccine components should not receive the vaccine. If any discomfort occurs after vaccination, it is important to promptly inform the physician to determine whether subsequent doses can be continued.